Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Aug 2022 – 20 Aug 2026, limited by quant Large Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant Large Cap Fund | Nifty 100 |
|---|---|---|
| 12 Aug 2022 | ₹100.00 | ₹100.00 |
| 12 Dec 2022 | ₹103.52 | ₹104.09 |
| 14 Apr 2023 | ₹94.41 | ₹98.21 |
| 14 Aug 2023 | ₹107.01 | ₹107.65 |
| 15 Dec 2023 | ₹123.38 | ₹120.26 |
| 15 Apr 2024 | ₹145.05 | ₹127.90 |
| 16 Aug 2024 | ₹154.65 | ₹142.44 |
| 16 Dec 2024 | ₹151.87 | ₹142.86 |
| 17 Apr 2025 | ₹137.71 | ₹135.98 |
| 18 Aug 2025 | ₹147.18 | ₹141.96 |
| 18 Dec 2025 | ₹149.69 | ₹146.60 |
| 20 Apr 2026 | ₹146.13 | ₹140.63 |
| 20 Aug 2026 | ₹157.77 | ₹141.41 |
| Metric | quant · Regular · IDCW NAV ₹15.79 Very High risk ★★★★☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| +6.03% | -5.49% | |
| +13.52% | +7.73% | |
| — | +6.21% | |
| — | +4.02% | |
| +12.00% | +5.54% | |
| +10.65% | — | |
| +14.47% | +6.92% | |
| — | +6.12% | |
| — | +3.99% | |
| Risk | ||
| 15.95% | 14.74% | |
| 0.44 | 0.02 | |
| 0.61 | 0.03 | |
| -22.02% | -48.01% | |
| Nifty 100 | — | |
| +3.26% | -1.74% | |
| 1.13 | 0.98 | |
| 117.2% | 93.8% | |
| 104.9% | 102.3% | |
| 2.89% | 2.38% | |
| ₹3,172Cr | ₹1,495Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 58% | |
| Sanjeev Sharma | — | |
| 12 Aug 2022 | — | |
| 11 | — | |
| 71.0% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.